Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: What's left of PDSG?

Thanks. Vigilys is the subsidiary of CrossFlow (acquisition funded by PTSC). So it looks like all that's left of PDSG at this point is CrossFlow and its subsidiary, Vigilys. It also appears that PTSC owns CrossFlow and Vigilys out right (where I thought it was just part ownership through an equity interest). It's a good thing I'm re-educating myself!

SGE

Share
New Message
Please login to post a reply